Company: ELV
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001156039-25-000010
Chunk: 230

Company: Elevance Health, Inc.
Filing Date: 2025-02-20
Form: 10-K
Item: Item 8
Chunk 230
---
 as follows:

 -131-

Elevance Health, Inc.Notes to Consolidated Financial Statements (continued)

CarelonHealth BenefitsCarelonRxCarelon ServicesTotalCorporate & OtherEliminationsTotalYear Ended December 31, 2024Premiums$142,668 $— $2,630 $2,630 $— $(1,132)$144,166 Product revenue— 22,630 — 22,630 — — 22,630 Service fees7,607 5 790 795 6 — 8,408 Operating revenue - unaffiliated150,275 22,635 3,420 26,055 6 (1,132)175,204 Operating revenue - affiliated— 13,326 14,541 27,867 303 (28,170)— Operating revenue - total$150,275 $35,961 $17,961 $53,922 $309 $(29,302)$175,204 Benefit expense$126,703 $— $14,388 $14,388 $19 $(13,543)$127,567 Cost of products sold— 32,978 — 32,978 — (13,228)19,750 Operating expense17,329 811 2,856 3,667 1,560 (2,531)20,025 Operating gain (loss)$6,243 $2,172 $717 $2,889 $(1,270)$— $7,862 Year Ended December 31, 2023Premiums$141,515 $— $1,679 $1,679 $— $(340)$142,854 Product revenue— 19,452 — 19,452 — — 19,452 Service fees7,056 6 813 819 28 — 7,903 Operating revenue - unaffiliated148,571 19,458 2,492 21,950 28 (340)170,209 Operating revenue - affiliated— 14,377 11,655 26,032 451 (26,483)— Operating revenue - total$148,571 $33,835 $14,147 $47,982 $479 $(26,823)$170,